← feed

Is NCT03544996 results overdue?

Yes — results are overdue. Primary completion was 2018-02-04; the FDAAA-801 reporting deadline (2019-02-04) passed 2740 days ago and no results are posted on ClinicalTrials.gov.

Transdermally Delivered Human Insulin Product

NCT IDNCT03544996 ↗
SponsorTransdermal Delivery Solutions Corp (INDUSTRY)
Phase
StatusCOMPLETED
Primary completion2018-02-04 (ACTUAL)
Reporting deadline2019-02-04 (completion + 365d)
Days overdue2740
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 04001fe08585ff66… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03544996. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →